Evidence map›Paper›PMID 22025714›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition.

Jordan R Beach, George S Hussey, Tyler E Miller, Arindam Chaudhury, Purvi Patel, James Monslow, Qiao Zheng, Ruth A Keri, Ofer Reizes, Anne R Bresnick and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Article
  2. Review
  3. A thermodynamic perspective on mammalian neural crest ingression.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Non-Muscle Myosin II A: Friend or Foe in Cancer?International journal of molecular sciences · 2024
    Review
  6. Regulation of Notch signaling by non-muscle myosin II Zipper in Drosophila.Cellular and molecular life sciences : CMLS · 2024
    Article
  7. In silico investigation of cannabinoids fromIn silico pharmacology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jordan R BeachDepartment of Cell Biology, Cleveland Clinic, Cleveland, OH 44195, USA.
George S Hussey
Tyler E Miller
Arindam Chaudhury
Purvi Patel
James Monslow
Qiao Zheng
Ruth A Keri
Ofer Reizes
Anne R Bresnick
Philip H Howe
Thomas T Egelhoff

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
TGF-regulated EMTR01CA154663 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Philip H Howe · 2011 to 2026
$5.1M
Myosin Assembly in DictyosteliumR01GM050009 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI EGELHOFF, THOMAS · 1998 to 2017
$4.7M
Regulation of erbB2/Neu-induced mammary gland cancerR01CA090398 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KERI, RUTH A. · 2001 to 2011
$2.7M
Myosin II Dynamics and Assembly in Mammalian CellsR01GM077224 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI EGELHOFF, THOMAS · 2007 to 2010
$1.1M
CELLULAR APPROACHES TO MYOSIN REGULATIONR29GM050009 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI EGELHOFF, THOMAS T · 1993 to 1997
–
NCI NIH HHS CA090398NCI NIH HHS CA100324NCI NIH HHS P01 CA100324NCI NIH HHS R01 CA090398NCI NIH HHS R01 CA154663NIGMS NIH HHS GM 077224NIGMS NIH HHS GM 50009NIGMS NIH HHS R01 GM050009NIGMS NIH HHS R01 GM077224NIGMS NIH HHS T32 GM007250NIGMS NIH HHS T32-GM07250
6 · The paper itself

Abstract

Despite functional significance of nonmuscle myosin II in cell migration and invasion, its role in epithelial-mesenchymal transition (EMT) or TGF-β signaling is unknown. Analysis of normal mammary gland expression revealed that myosin IIC is expressed in luminal cells, whereas myosin IIB expression is up-regulated in myoepithelial cells that have more mesenchymal characteristics. Furthermore, TGF-β induction of EMT in nontransformed murine mammary gland epithelial cells results in an isoform switch from myosin IIC to myosin IIB and increased phosphorylation of myosin heavy chain (MHC) IIA on target sites known to regulate filament dynamics (S1916, S1943). These expression and phosphorylation changes are downstream of heterogeneous nuclear ribonucleoprotein-E1 (E1), an effector of TGF-β signaling. E1 knockdown drives cells into a migratory, invasive mesenchymal state and concomitantly up-regulates MHC IIB expression and MHC IIA phosphorylation. Abrogation of myosin IIB expression in the E1 knockdown cells has no effect on 2D migration but significantly reduced transmigration and macrophage-stimulated collagen invasion. These studies indicate that transition between myosin IIC/myosin IIB expression is a critical feature of EMT that contributes to increases in invasive behavior.

Indexed as

Epithelial-Mesenchymal TransitionAnimalsCell LineMiceMyosin Type IIPhosphorylationProtein IsoformsTransforming Growth Factor betaMyosin Type IIProtein IsoformsTransforming Growth Factor beta

Identifiers

PMID22025714
PMCPMC3207690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.